시장보고서
상품코드
2092772

가치 기반 헬스케어 시장 : 구성 요소별, 결제 모델별, 용도별, 최종 용도별, 국가별, 지역별 - 업계 분석, 시장 규모, 시장 점유율 및 예측(2026-2033년)

Value-based Healthcare Market, By Component, By Payment Model, By Application, By End-Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

발행일: | 리서치사: 구분자 AnalystView Market Insights | 페이지 정보: 영문 352 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




가격
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.
US $ 3,250 금액 안내 화살표 ₩ 4,454,000
PDF (5 User License) help
PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,560 금액 안내 화살표 ₩ 6,249,000
PDF & Excel (Enterprise User License) help
PDF & Excel 보고서를 동일 기업 내 모든 사용자가 사용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 5,650 금액 안내 화살표 ₩ 7,743,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

가치 기반 헬스케어 시장 규모는 2025년에 688억 970만 달러로 평가되며, 2026-2033년에 CAGR 10.2%로 확대할 것으로 전망되고 있습니다.

가치 기반 의료란 환자의 건강 결과 개선과 의료 자원의 최적 활용을 중시하는 의료 모델입니다. 이 모델은 치료나 시술 횟수가 아니라, 간호의 질과 효과성에 중점을 두고 있습니다. 이러한 접근 방식을 통해 의료 제공자는 환자와 긴밀히 협력하여 유기적으로 연계된 서비스를 제공하고, 예방 가능한 질환을 사전에 차단하며, 장기적인 건강 상태 개선을 도모할 수 있게 됩니다.

가치 기반 의료 시장 - 시장 역학

만성질환 유병률의 증가와 보상 체계의 도입 확대가 시장 수요를 견인할 것으로 예상됩니다.

의료비 급등, 만성질환 유병률 증가, 그리고 보다 효율적으로 양질의 의료 서비스를 제공해야 할 필요성으로 인해 의료 기관들은 가치 기반 의료 모델로 전환하고 있으며, 이로 인해 가치 기반 의료 시장의 성장이 촉진되고 있습니다. 이러한 모델들은 제공된 서비스의 양에 따라 보상을 지급할 뿐만 아니라, 환자의 건강 결과 개선에 중점을 두고 있습니다. 그 결과, 정부, 보험사, 의료 제공자들은 예방 의료, 조기 개입 및 치료의 연속성 측면에서 협력을 강화하도록 장려하는 지불 체계를 점점 더 지지하고 있습니다. 이러한 변화의 배경에 있는 주요 요인 중 하나는 당뇨병, 심장병, 호흡기 질환 등 만성질환을 앓고 있는 사람들의 증가입니다. 이러한 질환들은 지속적인 치료가 필요하며, 전 세계 의료비의 상당 부분을 차지하고 있습니다. 세계보건기구(WHO)의 자료에 따르면 만성질환은 전 세계 사망 원인의 74%에 가까운 비중을 차지하고 있으며, 보다 효과적이고 환자 중심의 치료 전략의 중요성이 부각되고 있습니다. 가치 기반 의료는 적극적인 질환 관리를 촉진하고 예방 가능한 외래 진료를 줄임으로써 이러한 과제 해결에 기여합니다.

고품질의 의료 서비스를 제공하면서도 비용을 보다 효과적으로 관리해야 한다는 의료 제공자에 대한 압박이 커지면서, 가치 기반 의료 모델의 도입이 가속화되고 있습니다. 또한 정부, 보험사, 의료기관은 환자의 치료 결과, 예방 의료, 그리고 진료팀 간의 협력 강화를 우선시하는 지불 구조에 대한 투자를 점점 더 늘리고 있습니다. 많은 지역에서 의료 시스템은 보다 효율적인 의료 서비스 제공을 촉진하기 위해 ‘책임 의료(Accountable Care)’ 구상과 일괄 지급 프로그램을 확대하고 있습니다. 또한 민간 보험사들은 지급액을 달성된 결과의 질에 연동시키는 보상 계약을 도입하고 있습니다. 원격의료 서비스와 원격 환자 모니터링 기술의 활용 확대는 의료 제공자가 환자와의 유대 관계를 유지하고, 건강 상태를 보다 면밀히 모니터링하며, 기존의 의료 현장 이외의 곳에서도 적시에 개입할 수 있게 함으로써 이러한 전환을 더욱 촉진하고 있습니다.

가치 기반 의료 시장의 시장 세분화 분석:

전 세계 가치 기반 의료 시장은 구성 요소, 지불 모델, 용도, 최종 용도 및 지역별로 세분화되어 있습니다.

시장은 지급 모델에 따라 성과 연계형 보상(P4P), 일괄 지급, 이익 분배 프로그램, 기타 등 4가지 범주로 분류됩니다. 성과 연계형 보상(P4P) 부문은 지급 모델 부문에서 큰 비중을 차지하고 있습니다. 성과 연동형 보상은 도입이 용이하고 의료 시스템 전반에서 폭넓게 수용되고 있으며, 수요가 증가하고 있습니다. 이 모델에서 의료 제공자는 치료의 질, 환자 안전 및 건강 결과와 관련된 특정 목표를 달성한 대가로 보상을 받습니다. 또한 P4P는 대대적인 업무 변경 없이도 기존의 지급 구조에 통합할 수 있으며, 가치 기반 의료로 전환을 목표로 하는 조직에 실용적인 방안을 제시하고 있습니다.

가치 기반 의료 시장 - 지역별 분석

북미는 첨단인 의료 인프라, 디지털 헬스의 광범위한 도입, 그리고 서비스 양보다 환자의 치료 결과를 우선시하는 강력한 보험 지급 개혁에 힘입어 가치 기반 의료 시장의 매출 점유율 대부분을 차지하고 있습니다. 미국은 여전히 주요 기여국이며, 의료 제공자들은 치료의 질을 향상시키고 불필요한 지출을 줄이는 것을 목표로 하는 가치 기반 지불 프로그램에 점점 더 많이 참여하고 있습니다. 아시아태평양에서는 의료의 급속한 현대화와 보험 적용 범위 확대가 수요를 견인하고 있습니다. 이 지역의 성장을 주도하는 주요 동향으로는 예방 의료 및 맞춤형 의료를 지원하기 위한 원격의료, 전자 진료 기록, 예측 분석의 활용 확대가 꼽힙니다. 또한 예방의료에 대한 인식이 높아지고 고령화 사회에 대응할 필요성이 대두됨에 따라 한국, 중국, 인도 등 여러 국가에서 가치 기반 의료 프레임워크의 도입이 추진되고 있습니다.

목차

제1장 가치 기반 헬스케어 시장 개요

제2장 개요

제3장 가치 기반 헬스케어 주요 시장 동향

제4장 가치 기반 헬스케어 산업 분석

제5장 가치 기반 헬스케어 시장 : 높아지는 지정학적 긴장의 영향

제6장 가치 기반 헬스케어 시장 구도

제7장 가치 기반 헬스케어 시장 : 컴포넌트별

제8장 가치 기반 헬스케어 시장 : 결제 모델별

제9장 가치 기반 헬스케어 시장 : 용도별

제10장 가치 기반 헬스케어 시장 : 최종 사용별

제11장 가치 기반 헬스케어 시장 : 지역별

제12장 주요 벤더 분석 : 가치 기반 헬스케어 산업

제13장 AnalystView의 전방위 전망

KSA 26.07.29

Value-based Healthcare Market size was valued at USD 68,809.7 Million in 2025, expanding to a CAGR of 10.2% from 2026 to 2033.

Value-based healthcare is a model of care that emphasizes better health outcomes for patients, and the best use of healthcare resources. It is concerned with the quality and effectiveness of care, not the number of treatments or procedures. This approach encourages healthcare providers to work closely with patients, provide coordinated services, prevent illnesses that could be avoided, and improve health over the long term.

Value-based Healthcare Market- Market Dynamics

Rising prevalence of chronic disorders, and increased adoption of reimbursement frameworks are expected to propel market demand

Rising healthcare costs, the growing prevalence of chronic disorders, and the need to deliver better care more efficiently are driving healthcare organizations toward value-based care models, thereby boosting value-based healthcare market growth. Besides rewarding the volume of services provided, these models focus on achieving better health outcomes for patients. As a result, governments, insurers and health care providers are increasingly backing payment systems that incentivize preventive care, early intervention and improved coordination along the care continuum. One of the key factors behind this change is the rising number of people with chronic conditions such as diabetes, heart disease and respiratory disorders. These illnesses require ongoing treatment and account for a large share of healthcare spending worldwide. According to he World Health Organization data, chronic diseases contribute to nearly 74% of global deaths, emphasizing the importance of more effective and patient-centered care strategies. Value-based healthcare helps address these challenges by promoting proactive disease management, reducing preventable hospital visits.

Growing pressure on healthcare providers to deliver high-quality care while managing costs more effectively is accelerating the adoption of value-based healthcare models. Moreover, governments, insurers, and healthcare organizations are increasingly investing in payment structures that prioritize patient outcomes, preventive healthcare, and better coordination among care teams. Across many regions, healthcare systems are expanding accountable care initiatives and bundled payment programs to encourage more efficient care delivery. Further, private insurers are introducing reimbursement agreements that link payments to the quality of outcomes achieved. The increasing use of telehealth services and remote patient monitoring technologies is further supporting this transition by helping providers stay connected with patients, monitor their health more closely, and deliver timely interventions outside traditional healthcare settings.

Value-based Healthcare Market- Segmentation Analysis:

The Global Value-based Healthcare Market is segmented on the basis of Component, Payment Model, Application, End-Use, and Region.

The market is divided into four categories based on Payment Model: Pay-for-Performance (P4P), bundled payments, shared savings program, and others. Pay-for-Performance (P4P) segment attributed for a significant share in payment model segment. Pay-for-Performance is high in demand due to its ease of adoption and broader acceptance across healthcare systems. In this model, healthcare providers are rewarded for achieving specific goals related to care quality, patient safety, and health outcomes. Further, P4P can be incorporated into existing payment structures without requiring major operational changes, it offers a practical pathway for organizations transitioning toward value-based care.

Value-based Healthcare Market- Geographical Insights

North America holds the large chunk of revenue share of the value-based healthcare market, supported by advanced healthcare infrastructure, extensive digital health adoption, and strong reimbursement reforms that prioritize patient outcomes over service volume. The United States remains the key contributor, with healthcare providers increasingly joining in value-based payment programs designed to improve care quality and reduce unnecessary spending. In Asia Pacific, rapid healthcare modernization, expanding insurance coverage are fueling demand. A key trend shaping regional growth is the growing use of telehealth, electronic health records, and predictive analytics to support preventive and personalized care. Additionally, rising awareness of preventive healthcare and the need to manage aging populations are encouraging the adoption of value-based care frameworks across countries such as South Korea, China, India, etc.

South Korea Value-based Healthcare Market- Key Insights

South Korea's value-based healthcare market is picking up pace as the country is increasingly focusing on enhancing healthcare quality through digital innovation. Technologies like electronic medical records, artificial intelligence, advanced data analytics etc, are being increasingly adopted by hospitals and healthcare providers. The government is also supporting a more integrated approach to healthcare, particularly for older populations and those with long-term health conditions. This has led to an increased focus on quality of care, patient outcomes and overall treatment efficacy for healthcare organizations. Much of the hospital and clinic focus is on better coordination across health-care teams, improved patient experiences and reduced unnecessary medical spending.

With healthcare costs rising and the demand for better health outcomes growing, South Korea is slowly shifting away from volume-based care to models that reward quality and efficiency. Continued investments in healthcare technology, supportive policy initiatives, and a strong commitment to patient-centered care are helping drive the expansion of value-based healthcare services.

Value-based Healthcare Market- Competitive Landscape:

The value-based healthcare market is witnessing growing competition as healthcare providers, technology companies, insurers, and consulting organizations focus on delivering better patient outcomes while improving cost efficiency. Leading companies, including UnitedHealth Group, CVS Health, Veradigm, Oracle Health, and Evolent Health, are expanding their capabilities through investments in advanced analytics, care management technologies, etc. In addition, companies are increasingly pursuing partnerships, collaborations, and acquisitions to expand their service offerings and strengthen their presence in the value-based care ecosystem. These strategies are helping organizations improve care coordination, support data-driven decision-making, and meet the evolving needs of healthcare providers transitioning toward outcome-focused care models.

Recent Developments:

In January 2025, UnitedHealth Group continued to bolster its value-based care strategy through Optum, expanding the reach of its outcome-focused healthcare programs to around 4.7 million patients. The company's growing participation in value-based care reflects its focus on improving patient outcomes, enhancing care coordination, and reducing overall healthcare costs through more integrated and preventive care approaches.

In May 2025, CVS Health (Aetna) enhanced its value-based healthcare approach by launching new care coordination initiatives designed to streamline patient care. The company introduced bundled authorization processes for selected cancer-related diagnostic services and expanded its Clinical Collaboration program.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL VALUE-BASED HEALTHCARE MARKET KEY PLAYERS

  • UnitedHealth Group
  • Signify Health
  • Change Healthcare / Optum
  • Athenahealth
  • Koninklijke Philips N.V.
  • Siemens Healthineers
  • Deloitte
  • Baker Tilly US, LLP
  • CVS Health
  • Oracle Health
  • Evolent Health
  • Veradigm
  • Cigna Healthcare
  • Humana Inc.
  • Aledade
  • Health Catalyst
  • Teladoc Health
  • Arcadia
  • Innovaccer
  • WellSky
  • MVP Healthcare
  • McKesson Corporation
  • Others

GLOBAL VALUE-BASED HEALTHCARE MARKET, BY COMPONENT- MARKET ANALYSIS, 2020-2033

  • Solution
  • Electronic Health Records (EHR) Integration
  • Data Analytics
  • Care Platforms
  • Services

GLOBAL VALUE-BASED HEALTHCARE MARKET, BY PAYMENT MODEL- MARKET ANALYSIS, 2020-2033

  • Pay-for-Performance (P4P)
  • Bundled payments
  • Shared savings program
  • Others

GLOBAL VALUE-BASED HEALTHCARE MARKET, BY APPLICATION- MARKET ANALYSIS, 2020-2033

  • Preventive Care Management
  • Care Co-ordination & Patient Engagement
  • Risk Management
  • Others

GLOBAL VALUE-BASED HEALTHCARE MARKET, BY END-USE- MARKET ANALYSIS, 2020-2033

  • Healthcare Providers
  • Hospitals & Clinics
  • Physician Groups / ACOs
  • Healthcare Payers
  • Government Organizations
  • Others

GLOBAL VALUE-BASED HEALTHCARE MARKET, BY REGION- MARKET ANALYSIS, 2020-2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Value-based Healthcare Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Value-based Healthcare Market Snippet by Component
    • 2.1.2. Value-based Healthcare Market Snippet by Payment Model
    • 2.1.3. Value-based Healthcare Market Snippet by Application
    • 2.1.4. Value-based Healthcare Market Snippet by End-Use
    • 2.1.5. Value-based Healthcare Market Snippet by Country
    • 2.1.6. Value-based Healthcare Market Snippet by Region
  • 2.2. Competitive Insights

3. Value-based Healthcare Key Market Trends

  • 3.1. Value-based Healthcare Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Value-based Healthcare Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Value-based Healthcare Market Opportunities
  • 3.4. Value-based Healthcare Market Future Trends

4. Value-based Healthcare Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Value-based Healthcare Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Value-based Healthcare Market Landscape

  • 6.1. Value-based Healthcare Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Value-based Healthcare Market - By Component

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Component, 2025 & 2033 (%)
    • 7.1.2. Solution
      • 7.1.2.1. Electronic Health Records (EHR) Integration
      • 7.1.2.2. Data Analytics
      • 7.1.2.3. Care Platforms
    • 7.1.3. Services

8. Value-based Healthcare Market - By Payment Model

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Payment Model, 2025 & 2033 (%)
    • 8.1.2. Pay-for-Performance (P4P)
    • 8.1.3. Bundled payments
    • 8.1.4. Shared savings program
    • 8.1.5. Others

9. Value-based Healthcare Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 9.1.2. Preventive Care Management
    • 9.1.3. Care Co-ordination & Patient Engagement
    • 9.1.4. Risk Management
    • 9.1.5. Others

10. Value-based Healthcare Market - By End-Use

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-Use, 2025 & 2033 (%)
    • 10.1.2. Healthcare Providers
      • 10.1.2.1. Hospitals & Clinics
      • 10.1.2.2. Physician Groups / ACOs
    • 10.1.3. Healthcare Payers
    • 10.1.4. Government Organizations
    • 10.1.5. Others

11. Value-based Healthcare Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Value-based Healthcare Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Value-based Healthcare Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Value-based Healthcare Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Value-based Healthcare Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Value-based Healthcare Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)

12. Key Vendor Analysis- Value-based Healthcare Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. UnitedHealth Group
    • 12.2.2. Signify Health
    • 12.2.3. Change Healthcare / Optum
    • 12.2.4. Athenahealth
    • 12.2.5. Koninklijke Philips N.V.
    • 12.2.6. Siemens Healthineers
    • 12.2.7. Deloitte
    • 12.2.8. Baker Tilly US, LLP
    • 12.2.9. CVS Health
    • 12.2.10. Oracle Health
    • 12.2.11. Evolent Health
    • 12.2.12. Veradigm
    • 12.2.13. Cigna Healthcare
    • 12.2.14. Humana Inc.
    • 12.2.15. Aledade
    • 12.2.16. Health Catalyst
    • 12.2.17. Teladoc Health
    • 12.2.18. Arcadia
    • 12.2.19. Innovaccer
    • 12.2.20. WellSky
    • 12.2.21. MVP Healthcare
    • 12.2.22. McKesson Corporation
    • 12.2.23. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기